355 related articles for article (PubMed ID: 26337396)
81. Supragastric belches are the main determinants of troublesome belching symptoms in patients with gastro-oesophageal reflux disease.
Kessing BF; Bredenoord AJ; Velosa M; Smout AJ
Aliment Pharmacol Ther; 2012 May; 35(9):1073-9. PubMed ID: 22428801
[TBL] [Abstract][Full Text] [Related]
82. [Pathophysiology and Treatment of PPI-resistant NERD].
Kawami N; Iwakiri K; Sakamoto C
Nihon Rinsho; 2015 Jul; 73(7):1197-201. PubMed ID: 26165080
[TBL] [Abstract][Full Text] [Related]
83. [The value of twenty-four hour intraoesophageal pH monitoring and manometry in the management of patients with upper gastrointestinal symptoms].
Lakner L; Döbrönte Z
Orv Hetil; 2009 Oct; 150(43):1978-82. PubMed ID: 19812019
[TBL] [Abstract][Full Text] [Related]
84. Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD.
Tolone S; de Cassan C; de Bortoli N; Roman S; Galeazzi F; Salvador R; Marabotto E; Furnari M; Zentilin P; Marchi S; Bardini R; Sturniolo GC; Savarino V; Savarino E
Neurogastroenterol Motil; 2015 Aug; 27(8):1175-82. PubMed ID: 26010058
[TBL] [Abstract][Full Text] [Related]
85. Influence of gastric emptying on gastro-esophageal reflux: a combined pH-impedance study.
Gourcerol G; Benanni Y; Boueyre E; Leroi AM; Ducrotte P
Neurogastroenterol Motil; 2013 Oct; 25(10):800-e634. PubMed ID: 23848571
[TBL] [Abstract][Full Text] [Related]
86. The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors.
Yamashita H; Kanamori A; Kano C; Hashimura H; Matsumoto K; Tsujimae M; Yoshizaki T; Momose K; Obata D; Eguchi T; Fujita M; Okada A
Digestion; 2017; 96(1):52-59. PubMed ID: 28662503
[TBL] [Abstract][Full Text] [Related]
87. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus.
Emerenziani S; Sifrim D; Habib FI; Ribolsi M; Guarino MP; Rizzi M; Caviglia R; Petitti T; Cicala M
Gut; 2008 Apr; 57(4):443-7. PubMed ID: 17766596
[TBL] [Abstract][Full Text] [Related]
88. Proximal esophageal impedance baseline increases the yield of impedance-pH monitoring for GERD diagnosis and is associated with heartburn response to PPI.
Ribolsi M; Frazzoni M; Marchetti L; Brigida M; Cicala M; Savarino E
Neurogastroenterol Motil; 2023 Aug; 35(8):e14612. PubMed ID: 37203462
[TBL] [Abstract][Full Text] [Related]
89. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication.
Mainie I; Tutuian R; Agrawal A; Adams D; Castell DO
Br J Surg; 2006 Dec; 93(12):1483-7. PubMed ID: 17051602
[TBL] [Abstract][Full Text] [Related]
90. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
[TBL] [Abstract][Full Text] [Related]
91. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy.
Bredenoord AJ; Weusten BL; Timmer R; Conchillo JM; Smout AJ
Am J Gastroenterol; 2006 Mar; 101(3):453-9. PubMed ID: 16464226
[TBL] [Abstract][Full Text] [Related]
92. Multichannel intraluminal impedance and pH-metry for investigation of symptomatic gastroesophageal reflux disease.
Weigt J; Mönkemüller K; Peitz U; Malfertheiner P
Dig Dis; 2007; 25(3):179-82. PubMed ID: 17827936
[TBL] [Abstract][Full Text] [Related]
93. Proton pump inhibitors for reflux therapy in infants: effectiveness determined by impedance pH monitoring.
Castellani C; Huber-Zeyringer A; Bachmaier G; Saxena AK; Höllwarth ME
Pediatr Surg Int; 2014 Apr; 30(4):381-5. PubMed ID: 24488061
[TBL] [Abstract][Full Text] [Related]
94. Ambulatory Reflux Monitoring Guides Proton Pump Inhibitor Discontinuation in Patients With Gastroesophageal Reflux Symptoms: A Clinical Trial.
Yadlapati R; Masihi M; Gyawali CP; Carlson DA; Kahrilas PJ; Nix BD; Jain A; Triggs JR; Vaezi MF; Kia L; Kaizer A; Pandolfino JE
Gastroenterology; 2021 Jan; 160(1):174-182.e1. PubMed ID: 32949568
[TBL] [Abstract][Full Text] [Related]
95. Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease.
Patel A; Sayuk GS; Gyawali CP
Clin Gastroenterol Hepatol; 2015 May; 13(5):884-91. PubMed ID: 25158924
[TBL] [Abstract][Full Text] [Related]
96. Prospective validation of reflux monitoring by impedance-pH in predicting PPI response in typical GERD.
Ribolsi M; Savarino E; Frazzoni M; Cicala M
Dig Liver Dis; 2023 Jun; 55(6):721-726. PubMed ID: 36572569
[TBL] [Abstract][Full Text] [Related]
97. Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease.
Vela MF
Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):665-72. PubMed ID: 19072344
[TBL] [Abstract][Full Text] [Related]
98. Reflux and belching after 270 degree versus 360 degree laparoscopic posterior fundoplication.
Broeders JA; Bredenoord AJ; Hazebroek EJ; Broeders IA; Gooszen HG; Smout AJ
Ann Surg; 2012 Jan; 255(1):59-65. PubMed ID: 22167002
[TBL] [Abstract][Full Text] [Related]
99. Gastroesophageal reflux monitoring: pH (catheter and capsule) and impedance.
Hong SK; Vaezi MF
Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):1-22, v. PubMed ID: 19232277
[TBL] [Abstract][Full Text] [Related]
100. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
Weigt J; Kandulski A; Büsch F; Malfertheiner P
Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
